Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · IEX Real-Time Price · USD
13.45
+0.38 (2.91%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Enanta Pharmaceuticals Market Cap
Enanta Pharmaceuticals has a market cap or net worth of $284.86 million as of July 2, 2024. Its market cap has decreased by -36.57% in one year.
Market Cap
284.86M
Enterprise Value
27.58M
1-Year Change
-36.57%
Ranking
Category
Stock Price
$13.45
Market Cap Chart
Since March 21, 2013, Enanta Pharmaceuticals's market cap has decreased from $289.30M to $284.86M, a decrease of -1.53%. That is a compound annual growth rate of -0.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 284.90M | 43.74% |
| Dec 29, 2023 | 198.20M | -79.51% |
| Dec 30, 2022 | 967.50M | -36.34% |
| Dec 31, 2021 | 1.52B | 79.81% |
| Dec 31, 2020 | 845.30M | -30.63% |
| Dec 31, 2019 | 1.22B | -11.43% |
| Dec 31, 2018 | 1.38B | 22.59% |
| Dec 29, 2017 | 1.12B | 75.96% |
| Dec 30, 2016 | 637.80M | 2.77% |
| Dec 31, 2015 | 620.60M | -34.40% |
| Dec 31, 2014 | 946.00M | 93.06% |
| Dec 31, 2013 | 490.00M | 69.37% |
| Mar 21, 2013 | 289.30M | - |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Accolade | 285.23M |
| Zynex | 285.02M |
| LifeMD | 282.62M |
| Atea Pharmaceuticals | 280.72M |
| Kamada | 278.18M |
| Tactile Systems Technology | 273.74M |
| Inozyme Pharma | 272.47M |
| MacroGenics | 268.38M |